skip to main content

Chemistry, part 2

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

organooxygen compound > oxacycle > oxadiazole > 1,2,5-oxadiazole > 4-[5-(4-methyl-1,2,5-oxadiazol-3-yl)-1h-1,2,4-triazol-3-yl]-1,2,5-oxadiazol-3-amine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > oxadiazole > 1,2,5-oxadiazole > 4-[5-(4-methyl-1,2,5-oxadiazol-3-yl)-1h-1,2,4-triazol-3-yl]-1,2,5-oxadiazol-3-amine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > oxadiazole > 1,2,5-oxadiazole > 4-[5-(4-methyl-1,2,5-oxadiazol-3-yl)-1h-1,2,4-triazol-3-yl]-1,2,5-oxadiazol-3-amine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > oxadiazole > 1,2,5-oxadiazole > 4-[5-(4-methyl-1,2,5-oxadiazol-3-yl)-1h-1,2,4-triazol-3-yl]-1,2,5-oxadiazol-3-amine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > oxadiazole > 1,2,5-oxadiazole > 4-[5-(4-methyl-1,2,5-oxadiazol-3-yl)-1h-1,2,4-triazol-3-yl]-1,2,5-oxadiazol-3-amine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > oxadiazole > 1,2,5-oxadiazole > 4-[5-(4-methyl-1,2,5-oxadiazol-3-yl)-1h-1,2,4-triazol-3-yl]-1,2,5-oxadiazol-3-amine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > oxadiazole > 1,2,5-oxadiazole > 4-[5-(4-methyl-1,2,5-oxadiazol-3-yl)-1h-1,2,4-triazol-3-yl]-1,2,5-oxadiazol-3-amine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > oxadiazole > 1,2,5-oxadiazole > 4-[5-(4-methyl-1,2,5-oxadiazol-3-yl)-1h-1,2,4-triazol-3-yl]-1,2,5-oxadiazol-3-amine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxadiazole > 1,2,5-oxadiazole > 4-[5-(4-methyl-1,2,5-oxadiazol-3-yl)-1h-1,2,4-triazol-3-yl]-1,2,5-oxadiazol-3-amine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxadiazole > 1,2,5-oxadiazole > 4-[5-(4-methyl-1,2,5-oxadiazol-3-yl)-1h-1,2,4-triazol-3-yl]-1,2,5-oxadiazol-3-amine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxadiazole > 1,2,5-oxadiazole > 4-[5-(4-methyl-1,2,5-oxadiazol-3-yl)-1h-1,2,4-triazol-3-yl]-1,2,5-oxadiazol-3-amine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > azole > triazoles > 4-[5-(4-methyl-1,2,5-oxadiazol-3-yl)-1h-1,2,4-triazol-3-yl]-1,2,5-oxadiazol-3-amine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > azole > triazoles > 4-[5-(4-methyl-1,2,5-oxadiazol-3-yl)-1h-1,2,4-triazol-3-yl]-1,2,5-oxadiazol-3-amine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > azole > triazoles > 4-[5-(4-methyl-1,2,5-oxadiazol-3-yl)-1h-1,2,4-triazol-3-yl]-1,2,5-oxadiazol-3-amine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > azole > triazoles > 4-[5-(4-methyl-1,2,5-oxadiazol-3-yl)-1h-1,2,4-triazol-3-yl]-1,2,5-oxadiazol-3-amine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic aromatic compound > heteroarene > monocyclic heteroarene > azole > triazoles > 4-[5-(4-methyl-1,2,5-oxadiazol-3-yl)-1h-1,2,4-triazol-3-yl]-1,2,5-oxadiazol-3-amine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > monocyclic heteroarene > azole > triazoles > 4-[5-(4-methyl-1,2,5-oxadiazol-3-yl)-1h-1,2,4-triazol-3-yl]-1,2,5-oxadiazol-3-amine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > monocyclic heteroarene > azole > triazoles > 4-[5-(4-methyl-1,2,5-oxadiazol-3-yl)-1h-1,2,4-triazol-3-yl]-1,2,5-oxadiazol-3-amine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > heteroarene > monocyclic heteroarene > azole > triazoles > 4-[5-(4-methyl-1,2,5-oxadiazol-3-yl)-1h-1,2,4-triazol-3-yl]-1,2,5-oxadiazol-3-amine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > monocyclic heteroarene > azole > triazoles > 4-[5-(4-methyl-1,2,5-oxadiazol-3-yl)-1h-1,2,4-triazol-3-yl]-1,2,5-oxadiazol-3-amine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > monocyclic heteroarene > azole > triazoles > 4-[5-(4-methyl-1,2,5-oxadiazol-3-yl)-1h-1,2,4-triazol-3-yl]-1,2,5-oxadiazol-3-amine

اصطلاح مرجح

4-[5-(4-methyl-1,2,5-oxadiazol-3-yl)-1h-1,2,4-triazol-3-yl]-1,2,5-oxadiazol-3-amine  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

مفهوم اعم

بار

  • 0

فرمول

  • C7H6N8O2

اینچی

  • InChI=1S/C7H6N8O2/c1-2-3(13-16-12-2)6-9-7(11-10-6)4-5(8)15-17-14-4/h1H3,(H2,8,15)(H,9,10,11)

اینچی‌کی

  • ZQZQNNAHUAEZSY-UHFFFAOYSA-N

جرم

  • 234.175

جرم تک‌ایزوتوپی

  • 234.06137

اسمایلٓ

  • CC1=NON=C1C2=NC(=NN2)C3=NON=C3N

زیرمجموعه

  • 2_STAR

در زبان های دیگر

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:105352

این مفهوم را بارگیری کن:

RDF/XML TURTLE JSON-LD